April 20, 2020

Weekly review: Why does Covid-19 kill some young, healthy people—and spare others?

Daily Briefing

    Why does Covid-19 kill some young, healthy people—and spare others? (Monday, April 13)
    Most young healthy adults who contract the new coronavirus experience mild symptoms, yet data shows a growing number are suddenly dying from Covid-19—and health experts are scrambling to figure out why the disease is so deadly for some, but not others.

    'If people saw this, they would stay home': Inside New York hospitals at Covid-19's peak (Tuesday, April 14)
    In an unprecedented move, journalists are entering the "hot zones" of New York hospitals to witness how Covid-19 has turned the state's hospitals into "war zone[s]," the New York Times and CNN report.

    Who's immune to the new coronavirus—and for how long? Here's what the research says. (Wednesday, April 15)
    A key unanswered Covid-19 question public health officials are examining is whether exposure to the virus could protect people from future infection. In a New York Times opinion piece, Marc Lipsitch, an epidemiologist and infectious disease specialist, explores the existing evidence on coronaviruses—and how those findings could influence policymakers' decisions on social distancing measures.

    How long will social distancing last? It could be years, experts warn. (Thursday, April 16)
    Many Americans are hopeful that the summer will mark the end of social distancing, but health experts are projecting that some forms of social distancing will be in place for months—with one group of researchers predicting the United States will need to practice intermittent social distancing through 2022.

    The biggest constraint on reopening hospitals hiding in plain sight: PPE (Friday, April 17)
    With the surge in Covid-19 admissions ebbing in some states, health care providers are beginning to think through how to reopen non-emergent and elective services. But Advisory Board's Steven Berkow highlights one piece of the equation that has fallen to the wayside: personal protective equipment—and three conversations clinical leaders should be having to address the problem.

    Have a Question?

    x

    Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.

    X
    Cookies help us improve your website experience. By using our website, you agree to our use of cookies.